Watson Pharmaceuticals, Inc. To Host Second Quarter 2005 Earnings Conference Call And Webcast

CORONA, Calif., July 14 /PRNewswire/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2005 financial results on Wednesday, July 27, 2005 after the close of the U.S. financial markets. The Company will also host a conference call and webcast at 5:00 p.m. Eastern Daylight Time (EDT) on Wednesday, July 27, 2005 to discuss the results and provide an outlook for the rest of 2005. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call’s conclusion and will remain available through 12:00 midnight EDT on August 7, 2005. The replay may be accessed by dialing (800) 642-1687 and entering pass code 7739093. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson’s Investor Relations Web site at http://ir.watsonpharm.com. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watsonpharm.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)

Photo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.

CONTACT: Investors, Patty Eisenhaur of Watson Pharmaceuticals, Inc.,+1-951-493-5611

MORE ON THIS TOPIC